Go to virtual 3D site
Research & Innovation 2021
Programme : Presentations by Room

Conference Hall Track 2

Tuesday, 23 February 2021

TBC
Tue23  Feb11:15am(15 mins)
2021-02-23 11:15:002021-02-23 11:30:00Europe/LondonSession at Research & Innovation 2021 https://www.myeventflo.com/eventflo.asp?evID=2297OnlineSanj Kumar, ELRIGinfo@elrig.org Holm Uhlig  
Room: Conference Hall Track 2
Bench to bedside Treg therapy development and delivery
Tue23  Feb11:35am(20 mins)
2021-02-23 11:35:002021-02-23 11:55:00Europe/LondonSession at Research & Innovation 2021 https://www.myeventflo.com/eventflo.asp?evID=2297OnlineSanj Kumar, ELRIGinfo@elrig.org Dr Ye Htun Oo  
Room: Conference Hall Track 2
Tue23  Feb11:55am(5 mins)
2021-02-23 11:55:002021-02-23 12:00:00Europe/LondonSession at Research & Innovation 2021 https://www.myeventflo.com/eventflo.asp?evID=2297OnlineSanj Kumar, ELRIGinfo@elrig.org Nexcelom Bioscience Ltd
type 17 immunity and arthritis
Tue23  Feb12:05pm(20 mins)
2021-02-23 12:05:002021-02-23 12:25:00Europe/LondonSession at Research & Innovation 2021 https://www.myeventflo.com/eventflo.asp?evID=2297OnlineSanj Kumar, ELRIGinfo@elrig.org Dr Hussein Al-Mossawi  
Room: Conference Hall Track 2
Tue23  Feb12:45pm(30 mins)
2021-02-23 12:45:002021-02-23 13:15:00Europe/LondonSession at Research & Innovation 2021 https://www.myeventflo.com/eventflo.asp?evID=2297OnlineSanj Kumar, ELRIGinfo@elrig.org Promega UK Ltd
Platinum Sponsors
Hepcidin and iron-mediated regulation of immunity
Tue23  Feb02:15pm(20 mins)
2021-02-23 14:15:002021-02-23 14:35:00Europe/LondonSession at Research & Innovation 2021 https://www.myeventflo.com/eventflo.asp?evID=2297OnlineSanj Kumar, ELRIGinfo@elrig.org Prof Hal Drakesmith Prof Hal Drakesmith  
Room: Conference Hall Track 2
Tue23  Feb02:35pm(15 mins)
2021-02-23 14:35:002021-02-23 14:50:00Europe/LondonSession at Research & Innovation 2021 https://www.myeventflo.com/eventflo.asp?evID=2297OnlineSanj Kumar, ELRIGinfo@elrig.org Merck
Presenter: Alex Ko - Global SMC™ Product Manager - EMD Millipore Corp., USA - alex.ko@milliporesigma.com Title: Characterization of SARS-CoV-2 RBD IgG humoral response using Single Molecule Counting (SMC™) technology Abstract: Immunoassay-based serology techniques play key roles in many SARS-CoV-2 research programs due to their ability to identify and characterize the immune response of individuals already infected by the virus through analysis of biomarkers such as immunoglobulins (Ig). However, the limited sensitivity and resolution offered by traditional assay platforms and their serology assays can leave unanswered crucial research questions. We harnessed the power of the Single Molecule Counting (SMC™) ultrasensitive immunoassay platform for the development of new products to address the scientific community’s needs including identifying low level SARS-CoV-2 mediated antibody response and resolving subtle differences in humoral immunity among individuals. The new SMC™ SARS-CoV-2 RBD IgG kit can be used by researchers to accurately understand the extent of SARS-CoV-2 infection in society, thoroughly profile immune responses after vaccine challenge, and understand heterogeneous responses to infection among individuals and subpopulations.’
Trained immunity in diabetes: new targets beyond glucose in diabetes spectrum diseases
Tue23  Feb02:50pm(20 mins)
2021-02-23 14:50:002021-02-23 15:10:00Europe/LondonSession at Research & Innovation 2021 https://www.myeventflo.com/eventflo.asp?evID=2297OnlineSanj Kumar, ELRIGinfo@elrig.org Prof Robin Choudhury  
Room: Conference Hall Track 2
Lactate: Fuelling the Fire Starter
Tue23  Feb03:15pm(20 mins)
2021-02-23 15:15:002021-02-23 15:35:00Europe/LondonSession at Research & Innovation 2021 https://www.myeventflo.com/eventflo.asp?evID=2297OnlineSanj Kumar, ELRIGinfo@elrig.org Dr Claudio Mauro Dr Claudio Mauro  
Room: Conference Hall Track 2

Wednesday, 24 February 2021

Mining the gut microbiome for novel antimicrobial pharmbiotics based on bacteriocins and phage
Wed24  Feb10:55am(15 mins)
2021-02-24 10:55:002021-02-24 11:10:00Europe/LondonSession at Research & Innovation 2021 https://www.myeventflo.com/eventflo.asp?evID=2297OnlineSanj Kumar, ELRIGinfo@elrig.org Prof Paul Ross Prof Paul Ross  
Room: Conference Hall Track 2
Wed24  Feb11:15am(15 mins)
2021-02-24 11:15:002021-02-24 11:30:00Europe/LondonSession at Research & Innovation 2021 https://www.myeventflo.com/eventflo.asp?evID=2297OnlineSanj Kumar, ELRIGinfo@elrig.org Promega UK Ltd
Translating precision in microbiome science into transformative medicines and biomarkers
Wed24  Feb11:30am(20 mins)
2021-02-24 11:30:002021-02-24 11:50:00Europe/LondonSession at Research & Innovation 2021 https://www.myeventflo.com/eventflo.asp?evID=2297OnlineSanj Kumar, ELRIGinfo@elrig.org Dr Anne Neville Dr Anne Neville  
Room: Conference Hall Track 2
Gut dysbiosis and response to cancer immunotherapy: from disease phenotyping to therapeutic targeting.
Wed24  Feb11:55am(20 mins)
2021-02-24 11:55:002021-02-24 12:15:00Europe/LondonSession at Research & Innovation 2021 https://www.myeventflo.com/eventflo.asp?evID=2297OnlineSanj Kumar, ELRIGinfo@elrig.org Dr David Pinato Dr David Pinato  
Room: Conference Hall Track 2
Wed24  Feb12:35pm(5 mins)
2021-02-24 12:35:002021-02-24 12:40:00Europe/LondonSession at Research & Innovation 2021 https://www.myeventflo.com/eventflo.asp?evID=2297OnlineSanj Kumar, ELRIGinfo@elrig.org Nexcelom Bioscience Ltd
Wed24  Feb12:40pm(15 mins)
2021-02-24 12:40:002021-02-24 12:55:00Europe/LondonSession at Research & Innovation 2021 https://www.myeventflo.com/eventflo.asp?evID=2297OnlineSanj Kumar, ELRIGinfo@elrig.org Luminex
Title - Luminex Flow cytometry and protein analysis tools for Drug Discovery research Presenter - Prabhjoat Chana, Field Application Scientist Luminex Corporation
Application of human genetics to improve causality in relationships between the gut microbiome and human disease
Wed24  Feb02:05pm(20 mins)
2021-02-24 14:05:002021-02-24 14:25:00Europe/LondonSession at Research & Innovation 2021 https://www.myeventflo.com/eventflo.asp?evID=2297OnlineSanj Kumar, ELRIGinfo@elrig.org Dr Kaitlin Wade Dr Kaitlin Wade  
Room: Conference Hall Track 2
Novel Immunotherapeutics to target Gram-negative bacterial infections
Wed24  Feb02:25pm(20 mins)
2021-02-24 14:25:002021-02-24 14:45:00Europe/LondonSession at Research & Innovation 2021 https://www.myeventflo.com/eventflo.asp?evID=2297OnlineSanj Kumar, ELRIGinfo@elrig.org Mike Westby Mike Westby  
Room: Conference Hall Track 2
Development of oligonucleotide antimicrobials to counter emerging infections
Wed24  Feb02:50pm(20 mins)
2021-02-24 14:50:002021-02-24 15:10:00Europe/LondonSession at Research & Innovation 2021 https://www.myeventflo.com/eventflo.asp?evID=2297OnlineSanj Kumar, ELRIGinfo@elrig.org Christian Grøndahl  
Room: Conference Hall Track 2
Machine Learning Guided Design of Novel Mode of Action Gram-negative Antibiotics
Wed24  Feb03:10pm(15 mins)
2021-02-24 15:10:002021-02-24 15:25:00Europe/LondonSession at Research & Innovation 2021 https://www.myeventflo.com/eventflo.asp?evID=2297OnlineSanj Kumar, ELRIGinfo@elrig.org Paul Finn  
Room: Conference Hall Track 2
Programme

Hosted By
ELRIG
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2003-2020